Concepts (95)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Coumarins | 1 | 2019 | 43 | 0.570 |
Why?
|
| NF-E2-Related Factor 2 | 1 | 2019 | 89 | 0.540 |
Why?
|
| Cytochrome P-450 CYP2D6 | 3 | 2024 | 19 | 0.480 |
Why?
|
| Hypertension | 3 | 2023 | 823 | 0.350 |
Why?
|
| Analgesics, Opioid | 2 | 2024 | 245 | 0.340 |
Why?
|
| Colitis, Ulcerative | 2 | 2022 | 68 | 0.330 |
Why?
|
| Lung Neoplasms | 2 | 2021 | 479 | 0.220 |
Why?
|
| Genetic Testing | 2 | 2022 | 90 | 0.220 |
Why?
|
| Multicenter Studies as Topic | 4 | 2024 | 61 | 0.200 |
Why?
|
| Genomics | 2 | 2022 | 289 | 0.200 |
Why?
|
| Pain, Postoperative | 1 | 2022 | 28 | 0.190 |
Why?
|
| Intestinal Mucosa | 2 | 2022 | 131 | 0.180 |
Why?
|
| Randomized Controlled Trials as Topic | 4 | 2024 | 358 | 0.180 |
Why?
|
| Benchmarking | 1 | 2021 | 33 | 0.180 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2021 | 42 | 0.180 |
Why?
|
| Colitis | 1 | 2022 | 69 | 0.170 |
Why?
|
| Genome | 1 | 2022 | 149 | 0.170 |
Why?
|
| Perioperative Care | 1 | 2020 | 10 | 0.170 |
Why?
|
| Paneth Cells | 1 | 2020 | 3 | 0.170 |
Why?
|
| Receptor, Melanocortin, Type 4 | 1 | 2020 | 9 | 0.170 |
Why?
|
| Intraoperative Complications | 1 | 2020 | 20 | 0.170 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2022 | 101 | 0.170 |
Why?
|
| Muramidase | 1 | 2020 | 31 | 0.170 |
Why?
|
| Carcinoma, Renal Cell | 1 | 2020 | 48 | 0.160 |
Why?
|
| Humans | 17 | 2024 | 42163 | 0.160 |
Why?
|
| Cannabinoids | 1 | 2020 | 67 | 0.160 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2022 | 188 | 0.150 |
Why?
|
| Substance Withdrawal Syndrome | 1 | 2020 | 126 | 0.150 |
Why?
|
| Mice, Knockout | 2 | 2020 | 1010 | 0.150 |
Why?
|
| Specific Pathogen-Free Organisms | 1 | 2019 | 23 | 0.150 |
Why?
|
| HT29 Cells | 1 | 2019 | 60 | 0.150 |
Why?
|
| Caco-2 Cells | 1 | 2019 | 59 | 0.150 |
Why?
|
| Postoperative Complications | 1 | 2020 | 253 | 0.150 |
Why?
|
| Receptors, Aryl Hydrocarbon | 1 | 2019 | 49 | 0.150 |
Why?
|
| Genome-Wide Association Study | 1 | 2020 | 421 | 0.140 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2019 | 88 | 0.140 |
Why?
|
| Prospective Studies | 4 | 2024 | 1574 | 0.140 |
Why?
|
| Genetic Variation | 1 | 2020 | 429 | 0.140 |
Why?
|
| Mice, Inbred C57BL | 2 | 2020 | 1804 | 0.130 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2019 | 130 | 0.130 |
Why?
|
| Depression | 1 | 2024 | 837 | 0.130 |
Why?
|
| Early Detection of Cancer | 1 | 2021 | 428 | 0.130 |
Why?
|
| Epithelial Cells | 1 | 2019 | 426 | 0.120 |
Why?
|
| Macrophages | 1 | 2019 | 515 | 0.110 |
Why?
|
| Blood Pressure | 3 | 2023 | 662 | 0.110 |
Why?
|
| Mice | 3 | 2022 | 6490 | 0.110 |
Why?
|
| Gene Expression Regulation | 1 | 2019 | 1066 | 0.100 |
Why?
|
| Cell Proliferation | 1 | 2019 | 1420 | 0.100 |
Why?
|
| Obesity | 1 | 2020 | 1131 | 0.090 |
Why?
|
| Female | 8 | 2024 | 24018 | 0.090 |
Why?
|
| Adult | 6 | 2024 | 13458 | 0.090 |
Why?
|
| Antihypertensive Agents | 2 | 2022 | 285 | 0.080 |
Why?
|
| Animals | 3 | 2022 | 16695 | 0.070 |
Why?
|
| Male | 6 | 2024 | 22779 | 0.070 |
Why?
|
| Neoplasms | 1 | 2019 | 1341 | 0.070 |
Why?
|
| Middle Aged | 4 | 2024 | 11819 | 0.060 |
Why?
|
| Antidepressive Agents | 1 | 2024 | 61 | 0.050 |
Why?
|
| Pain Measurement | 1 | 2024 | 181 | 0.050 |
Why?
|
| Aged | 3 | 2020 | 7982 | 0.050 |
Why?
|
| Codeine | 1 | 2022 | 3 | 0.050 |
Why?
|
| Tramadol | 1 | 2022 | 2 | 0.050 |
Why?
|
| Hydrocodone | 1 | 2022 | 3 | 0.050 |
Why?
|
| Seasons | 1 | 2023 | 133 | 0.050 |
Why?
|
| Genetic Counseling | 1 | 2022 | 13 | 0.050 |
Why?
|
| Dextran Sulfate | 1 | 2022 | 17 | 0.050 |
Why?
|
| Pharmacogenetics | 1 | 2022 | 63 | 0.050 |
Why?
|
| Disclosure | 1 | 2022 | 36 | 0.050 |
Why?
|
| Population Groups | 1 | 2022 | 59 | 0.050 |
Why?
|
| Temperature | 1 | 2023 | 314 | 0.050 |
Why?
|
| Laboratories | 1 | 2021 | 40 | 0.040 |
Why?
|
| Colon | 1 | 2022 | 118 | 0.040 |
Why?
|
| Delphi Technique | 1 | 2020 | 30 | 0.040 |
Why?
|
| Consensus | 1 | 2020 | 53 | 0.040 |
Why?
|
| STAT6 Transcription Factor | 1 | 2020 | 17 | 0.040 |
Why?
|
| Goblet Cells | 1 | 2020 | 12 | 0.040 |
Why?
|
| Drug Carriers | 1 | 2022 | 169 | 0.040 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2021 | 246 | 0.040 |
Why?
|
| Crohn Disease | 1 | 2020 | 69 | 0.040 |
Why?
|
| Phenotype | 1 | 2021 | 774 | 0.040 |
Why?
|
| Immunotherapy | 1 | 2020 | 137 | 0.040 |
Why?
|
| Cannabis | 1 | 2020 | 90 | 0.040 |
Why?
|
| Mice, Inbred BALB C | 1 | 2020 | 686 | 0.040 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2021 | 727 | 0.030 |
Why?
|
| Survival Analysis | 1 | 2019 | 362 | 0.030 |
Why?
|
| Mass Screening | 1 | 2021 | 531 | 0.030 |
Why?
|
| Base Sequence | 1 | 2019 | 997 | 0.030 |
Why?
|
| Immunohistochemistry | 1 | 2019 | 928 | 0.030 |
Why?
|
| Inflammation | 1 | 2022 | 729 | 0.030 |
Why?
|
| Body Mass Index | 1 | 2020 | 916 | 0.030 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2019 | 290 | 0.030 |
Why?
|
| Disease Models, Animal | 1 | 2022 | 1554 | 0.030 |
Why?
|
| Cohort Studies | 1 | 2020 | 1729 | 0.030 |
Why?
|
| RNA, Messenger | 1 | 2019 | 1265 | 0.030 |
Why?
|
| Cross-Sectional Studies | 1 | 2021 | 3077 | 0.030 |
Why?
|
| Aged, 80 and over | 1 | 2019 | 2803 | 0.020 |
Why?
|